CF Industries Delivers Impressive Q4 2025 Results, Crushing Wall Street Estimates

CF Industries reported exceptional fourth-quarter 2025 earnings that defied analyst expectations on both revenue and profitability fronts. The company posted $1.87 billion in quarterly revenue—a robust 22.8% jump from the same period a year earlier—and delivered earnings per share of $2.99, far exceeding the consensus forecast of $2.50. This performance underscores CF’s operational strength during a volatile commodity pricing environment.

Revenue Surprise: CF Outperforms Consensus Expectations

The headline numbers tell a compelling story. CF’s $1.87 billion revenue haul surpassed the Zacks consensus estimate of $1.79 billion by $80 million, translating to a +4.69% earnings surprise. More impressive was the EPS beat: at $2.99 versus the forecasted $2.50, CF delivered a +19.79% upside surprise. This dual outperformance suggests the company not only moved more product but also achieved better pricing and operational efficiency than Wall Street anticipated.

Product Line Performance: Mixed Results with Key Strengths

CF’s diversified fertilizer portfolio showed varied performance against analyst estimates. In Ammonia sales volume, the company shipped 1,272 KTon compared to the four-analyst average projection of 1,164.55 KTon—a notable outperformance. Notably, CF achieved $708 million in Ammonia net sales, representing a +23.8% year-over-year surge and exceeding the $570.71 million analyst consensus.

Granular Urea volumes came in lighter than expected at 857 KTon versus the estimated 1,021.51 KTon. However, CF more than compensated through superior pricing. The company’s average selling price of $434 per ton beat the three-analyst average estimate of $412.49, reflecting strong market demand. UAN (urea ammonium nitrate) sales reached $564 million, up an impressive +51.6% from the prior-year quarter and topping the $560.37 million consensus estimate.

Across the board, CF moved 4,528 KTon of total product volume—marginally below the four-analyst average estimate of 4,721.13 KTon. Yet this volume constraint did not derail profitability, as pricing power in key categories drove bottom-line results.

Comprehensive Sales Breakdown: Where CF Found Its Edge

Breaking down CF’s net sales by product reveals the company’s strategic performance drivers. AN (ammonium nitrate) sales declined to $81 million from the prior-year quarter, marking a -19.8% year-over-year dip and trailing the $71.74 million estimate slightly. Other sales segments generated $147 million, up 12.2% annually despite coming in modestly below the $153.66 million projection.

The Granular Urea segment delivered $372 million in net sales, reflecting a respectable +6.9% annual increase but falling short of the $423.03 million four-analyst average estimate. This underperformance in volume was offset by gains in higher-margin products like Ammonia.

Stock Momentum & Investment Outlook

CF shares gained +6.1% over the trailing month, outpacing the S&P 500 composite’s -1.3% performance during the same period. The stock currently carries a Zacks Rank #3 (Hold) rating, suggesting investors can expect CF to move broadly in line with broader market trends in the near term.

The strong earnings beat, robust year-over-year growth in high-margin products, and pricing power demonstrated across multiple product lines position CF favorably for sustained performance. However, the modest volume shortfall and mixed product-line results warrant careful monitoring as commodity cycles evolve.